Cha Jae Min, Park HyungDal, Shin Eun Kyoung, Sung Ji Hee, Kim Ockchul, Jung Woohyun, Bang Oh Young, Kim Jinseok
Medical Device Research Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Republic of Korea.
Biofabrication. 2017 Aug 14;9(3):035006. doi: 10.1088/1758-5090/aa8111.
Spheroid cultures have been often used to simulate and understand in situ biological occurrences with potential to be further applied to therapeutic approaches, such as cell transplantation. However, traditional lab-scale techniques hardly reached the needed large scale production of cell spheroids, thus limiting their versatility in many biomedical fields. Microscale technologies have rapidly improved in the last decade, and contributed to the large scale production of cell spheroids with high controllability and reproducibility. Nonetheless, the existing microwell culture platforms are problematic due to unwanted cellular adhesion to the substrate as well as due to substantial amounts of cell loss. In this study, we have developed a novel configuration of cylindrical type polyethylene glycol (PEG) hydrogel microwells featuring inverted-pyramidal openings (iPO). Highly refined microstructures of our novel microwell could be fabricated by our optimized micro-electro mechanical system protocols consisting of a silicon (Si) wet/dry etching, Si-to-polydimethylsiloxane substrate bonding, and the established soft-lithography techniques. The iPO, the PEG hydrogel, and the cylindrical geometry of our microwell successfully (1) avoided inefficient washing steps after cell seeding, (2) achieved the complete resistance to cellular adhesion on the microwell substrate, and (3) made all seeded cells readily gathered and jam-packed to form cell spheroids with uniform size, respectively. The maximal sizes of cell spheroids were confined to below 200 μm according to the size of microwells used in this study. The efficiency testing for cell spheroid formation was conducted in comparison with other types of microwells that have been often used in the fields. The results showed that our novel microwell platform effectively reached almost zero percent of cell loss while mass-producing human mesenchymal stem cell spheroids with highly precise control over spheroid's size and cell number. We believe that this study could deliver an effective method to extend the practical usability of cell spheroids in a variety of biomedical applications.
球体培养常常被用于模拟和理解原位生物学现象,并有可能进一步应用于治疗方法,如细胞移植。然而,传统的实验室规模技术很难实现所需的细胞球体大规模生产,从而限制了它们在许多生物医学领域的通用性。在过去十年中,微尺度技术迅速发展,有助于实现具有高可控性和可重复性的细胞球体大规模生产。尽管如此,现有的微孔培养平台存在问题,因为细胞会意外粘附在基质上,并且会有大量细胞损失。在本研究中,我们开发了一种新型的圆柱形聚乙二醇(PEG)水凝胶微孔结构,其具有倒金字塔形开口(iPO)。我们的新型微孔的高度精细微结构可以通过我们优化的微机电系统协议制造,该协议包括硅(Si)湿法/干法蚀刻、硅到聚二甲基硅氧烷衬底键合以及既定的软光刻技术。我们微孔的iPO、PEG水凝胶和圆柱形几何形状分别成功地(1)避免了细胞接种后低效的洗涤步骤,(2)实现了对微孔基质上细胞粘附的完全抗性,以及(3)使所有接种的细胞容易聚集并紧密堆积形成大小均匀的细胞球体。根据本研究中使用的微孔尺寸,细胞球体的最大尺寸限制在200μm以下。与该领域常用的其他类型微孔相比,进行了细胞球体形成的效率测试。结果表明,我们的新型微孔平台在大规模生产人间充质干细胞球体时,有效实现了几乎零细胞损失,同时对球体大小和细胞数量具有高度精确的控制。我们相信,这项研究可以提供一种有效的方法,以扩展细胞球体在各种生物医学应用中的实际可用性。